Inovio Pharmaceuticals Says FDA Actively Reviewing INO-3107 BLA Under Accelerated Approval With PDUFA Date Oct 30, 2026; Anticipates Cash Will Fund Operations Into Q1 2027, Beyond PDUFA Date